搜索临床试验以:Fabry, Fabry Disease, Alpha-galactosidase A deficiency, GLA gene, mutations
总计498917个结果
-
Children's Oncology GroupNational Cancer Institute (NCI)完全的卵巢癌 | 间质细胞瘤 | 儿童生殖细胞肿瘤
-
Children's Oncology GroupNational Cancer Institute (NCI)完全的肉瘤 | 肾癌 | 脑和中枢神经系统肿瘤 | 成神经细胞瘤 | 肝癌 | 胸膜肺母细胞瘤 | 遗传性肾母细胞瘤
-
National Heart Centre SingaporeSingapore General Hospital; Duke-NUS Graduate Medical School完全的
-
First People's Hospital of Hangzhou未知
-
Cancer Research UK完全的乳腺癌 | 卵巢癌 | brca1突变携带者 | brca2突变携带者英国
-
Children's Oncology GroupNational Cancer Institute (NCI)完全的
-
Children's Oncology GroupNational Cancer Institute (NCI)完全的睾丸生殖细胞肿瘤 | 卵巢癌 | 性腺外生殖细胞瘤 | 儿童生殖细胞肿瘤
-
AstraZenecaMyriad Genetic Laboratories, Inc.撤销
-
University of WashingtonNational Cancer Institute (NCI); National Institute of Nursing Research (NINR)完全的乳腺导管原位癌 | BRCA1突变携带者 | BRCA2突变携带者 | 非典型导管乳腺增生 | 小叶性乳腺癌原位癌 | 非典型小叶性乳腺增生美国
-
Southwest Oncology GroupNational Cancer Institute (NCI)完全的
-
Massachusetts General HospitalNovartis Pharmaceuticals撤销乳腺癌 | 大肠癌 | 肺癌 | 胆管癌 | 实体瘤
-
Gesellschaft fur Padiatrische Onkologie und Hamatologie...未知
-
National Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的IV 期结肠癌 | IV 期直肠癌 | 复发性结肠癌 | 复发性直肠癌 | 直肠腺癌 | III期结肠癌 | III期直肠癌 | 结肠腺癌美国
-
Grupo Español de Tumores Huérfanos e Infrecuentes终止
-
National Cancer Institute (NCI)终止未明确的成人实体瘤,特定方案 | 胰腺癌 | 复发性胰腺癌 | IV 期胰腺癌 | IV 期乳腺癌 | IV 期卵巢上皮癌 | IV 期卵巢生殖细胞肿瘤 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIIC期乳腺癌 | 复发性乳腺癌 | 复发性卵巢上皮癌 | IV 期结肠癌 | IV 期直肠癌 | IV 期胃癌 | 复发性结肠癌 | 复发性直肠癌 | 复发性胃癌 | 复发性卵巢生殖细胞肿瘤 | 胃腺癌 | 卵巢粘液性囊腺癌 | BRCA1突变携带者 | BRCA2突变携带者美国
-
Abramson Cancer Center of the University of PennsylvaniaNational Cancer Institute (NCI)未知
-
National Taiwan University Hospital未知
-
Children's Cancer and Leukaemia Group未知
-
The Christie NHS Foundation Trust未知肉瘤 | 宫颈癌 | 乳腺癌 | 卵巢癌 | 输卵管癌 | 前列腺癌 | 外阴癌 | 子宫内膜癌 | 阴道癌 | 原发性腹膜腔癌英国
-
The University of New South Wales完全的
-
University College London Hospitals完全的乳腺癌 | 遗传性乳腺癌/卵巢癌(brca1、brca2) | brca1突变携带者 | brca2突变携带者澳大利亚, 以色列, 英国, 西班牙, 瑞典, 葡萄牙
-
University of Alabama at BirminghamNational Cancer Institute (NCI)撤销卵巢癌 | brca1突变携带者 | brca2突变携带者美国
-
Catholic University of the Sacred Heart未知
-
GlaxoSmithKline完全的
-
University of North Carolina, Chapel HillElizabeth Glaser Pediatric AIDS Foundation完全的
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)完全的
-
IRCCS Policlinico S. MatteoGlaxoSmithKline; University of Pavia; Azienda Ospedaliera di Padova; Azienda Ospedaliera di Perugia 和其他合作者完全的
-
Clinical Research Center for Solid Tumor, KoreaSeoul National University Hospital; Korean Cancer Study Group终止
-
Hadassah Medical Organization未知
-
Chinese PLA General Hospital未知肿瘤,肺 | 癌,非小细胞肺癌 | 药物治疗 | Genes, EGFR中国